← Back to NASA Technology Projects
Completed TRL 9 (started at 5, targeting 9)
MEDLI2 will reduce uncertainty in aeroshell TPS response with the potential to reduce TPS mass by up to 130 kg for a Mars 2020 class mission. MEDLI2 will reduce uncertainty in supersonic aerodynamic predictions with the potential to reduce the landing footprint size by 30%. MEDLI2 fills critical EDL knowledge gaps which represent a technology advancement in EDL. MEDLI2 advances instrumentation development essential for EDL analysis.
Improved understanding of risk and performance leading to the ability to reduce entry mass and reduce size of landed footprint.
Listed on TechPort itself — the most direct way to ask about this specific project.
This is a mature technology (TRL 9) — the realistic path in is usually NASA's Technology Transfer Program: licensing an existing NASA patent, or a Space Act Agreement to use NASA facilities/expertise directly. NASA also runs a startup licensing program with no upfront fee for companies formed to commercialize a specific NASA technology.
None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.